Osteomyelitis is an infection of bone, typically caused by bacteria that invade bone tissue through the bloodstream, from a nearby wound, or during surgery. The infection triggers inflammation, can destroy bone from the inside out, and often proves stubbornly difficult to cure. While the word itself comes from the Greek roots for bone (osteon), marrow (myelo), and inflammation (itis), the clinical reality is far messier than that tidy etymology suggests. Osteomyelitis can strike anyone from newborns to the elderly, settle in virtually any bone in the body, and range from a fast-moving emergency to a smoldering chronic condition that flares up years after the original infection seemed resolved.
How Bacteria Reach Bone
Bone seems like a well-protected tissue, tucked beneath muscle and sealed inside a dense outer shell. Yet bacteria find their way in through three main routes. The most common in children is hematogenous spread, where bacteria circulating in the blood lodge in the richly vascularized ends of growing bones. A child with a minor skin infection or a sore throat can develop a bone infection days later in a completely different part of the body, because the bacteria hitched a ride through the bloodstream.
In adults, the most frequent path is contiguous spread, meaning the infection creeps into bone from adjacent soft tissue. This happens when a deep wound, a surgical incision, or a diabetic foot ulcer extends close enough to bone for bacteria to cross over. The third route is direct inoculation, where bacteria are introduced straight into bone during an open fracture, a joint replacement, or another surgical procedure. Each route tends to produce a somewhat different pattern of disease and affects different populations, but the end result is the same: bacteria colonizing bone tissue and provoking an inflammatory response that can rapidly damage the bone itself.
What Happens Inside Infected Bone
Once bacteria establish themselves in bone, a destructive cascade begins. The body floods the area with immune cells, creating pus and swelling inside the rigid confines of bone. That pressure compresses the tiny blood vessels feeding the bone from within, cutting off the blood supply to surrounding tissue. Without blood flow, patches of bone die. These dead fragments are called sequestra, and they become a major obstacle to healing. A sequestrum sits in the middle of the infection like a foreign body the immune system cannot reach or dissolve, and antibiotics delivered through the bloodstream have no way to penetrate dead tissue that lacks working blood vessels.
The body does mount a repair response. The periosteum, the tough membrane that wraps around the outside of bone, reacts to the infection by laying down new bone in an attempt to wall off the damage. This shell of new bone is called an involucrum. In children especially, the periosteum is thick and active, so involucrum formation can be substantial. But the new bone often forms around the dead bone rather than replacing it, creating a complicated mix of living and necrotic tissue riddled with pockets of infection.1PubMed. Sequestration and Involucrum: Understanding Bone Necrosis and Revascularization in Pediatric Orthopedics This is the fundamental reason osteomyelitis is so hard to eradicate: the infection creates its own fortress of dead tissue that shields bacteria from both the immune system and medication.
The Bacteria Behind It
The single most important organism in osteomyelitis is Staphylococcus aureus. Across all age groups and all routes of infection, S. aureus is responsible for the majority of cases. It is a common skin bacterium that most people carry harmlessly on their skin or in their nose, yet it has an extraordinary ability to adhere to bone, evade immune defenses, and persist inside bone cells themselves.2PubMed Central. Staphylococcal Osteomyelitis: Disease Progression, Treatment Challenges, and Future Directions Making matters worse, antibiotic-resistant strains, particularly methicillin-resistant S. aureus (MRSA), have become increasingly common, narrowing treatment options.3PubMed Central. Staphylococcus aureus Osteomyelitis: Bone, Bugs, and Surgery
Other bacteria play a role depending on the circumstances. In people with sickle cell disease, the pattern flips in a striking way. Salmonella species become the leading cause of osteomyelitis, accounting for roughly 60% of culture-positive cases in one large review, with S. aureus falling to second place at about 22%.4PubMed. Osteomyelitis in Sickle Cell Anemia: Does Age Predict Risk of Salmonella Infection? The reasons are tied to the disease itself: sickle-shaped red blood cells can block small blood vessels in bone, creating tiny areas of dead tissue that are especially hospitable to Salmonella, which the impaired spleen of sickle cell patients is less able to clear from the bloodstream.5PubMed. Salmonella osteomyelitis and arthritis in sickle cell disease In diabetic foot infections, mixed bacterial communities are common, with gram-negative organisms and anaerobes joining staphylococci. And in infections that develop after surgical hardware insertion, slower-growing bacteria like Staphylococcus epidermidis often take center stage, thriving on the surface of metal implants.
Why Biofilms Make Implant Infections So Stubborn
When bacteria land on the surface of a metal plate, screw, or artificial joint, they undergo a transformation. Individual free-floating bacteria settle onto the implant and begin producing a slimy matrix of sugars and proteins that glues them together into a structured community called a biofilm. Inside this biofilm, bacteria are shielded from both antibiotics and the immune system.6PubMed Central. Chronic Implant-Related Bone Infections-Can Immune Modulation be a Therapeutic Strategy? Antibiotic concentrations that would easily kill the same bacteria in a test tube fail to penetrate the biofilm’s protective layers, and immune cells that arrive at the scene cannot engulf bacteria embedded in the matrix.
This is why implant-associated osteomyelitis so often becomes chronic: the biofilm creates a reservoir of bacteria that antibiotics alone cannot clear. The practical consequence is that treatment frequently requires removing the infected hardware entirely, even if the original fracture or joint has not fully healed. Surgical removal of the biofilm-coated implant and thorough cleaning of the surrounding bone remain the most reliable way to eliminate the infection.7FEMS Immunology & Medical Microbiology. Osteomyelitis and the role of biofilms in chronic infection
Acute Versus Chronic Disease
Osteomyelitis is broadly divided into acute and chronic forms, and the distinction matters because the two behave differently under the microscope, respond differently to treatment, and carry different long-term risks. Acute osteomyelitis develops over days to weeks. The bone fills with pus and dying tissue. If examined under a microscope, the hallmark is swarms of neutrophils, the body’s frontline infection-fighting white blood cells, flooding the bone marrow spaces alongside areas of bone death.8PubMed Central. Histopathological Osteomyelitis Evaluation Score (HOES) – an innovative approach to histopathological diagnostics and scoring of osteomyelitis Patients with acute osteomyelitis typically have fever, severe localized pain, swelling, and blood tests showing a strong inflammatory response.
Chronic osteomyelitis, by contrast, is the smoldering result of an acute infection that was never fully eliminated, or it develops insidiously over months. The tissue picture shifts from acute inflammation to scarring: bone marrow becomes fibrotic, new reactive bone forms in disorganized layers, and the inflammatory cells change from neutrophils to lymphocytes, macrophages, and plasma cells. Clinically, chronic osteomyelitis is more subtle. Patients may have intermittent pain, a draining wound tract (called a sinus) that opens and closes over months or years, and relatively mild systemic symptoms between flares. The chronic form can persist for decades if not surgically addressed.
Staging the Disease
Clinicians have used several frameworks to classify osteomyelitis, and the two most widely referenced are the Waldvogel system and the Cierny-Mader system. The Waldvogel system, which dates to the 1970s, sorts cases by how the infection arrived: hematogenous (via the bloodstream), contiguous with or without blood vessel disease, or chronic. It is useful for understanding the origin of the infection, but it does not offer much guidance on what to do about it surgically.
The Cierny-Mader system, developed in the 1980s, takes a more treatment-oriented approach. It classifies the infection by the anatomy of the bone involvement (whether only the inner marrow cavity is affected, or the surface, or a localized segment, or the full thickness of bone) and also accounts for the overall health of the patient, distinguishing between a healthy host and one with systemic or local factors that impair healing.9PubMed. Staging and staging application in osteomyelitis The Cierny-Mader system is more practical for surgical planning because it helps the treatment team estimate whether the patient can tolerate aggressive surgery, whether a minor procedure might suffice, or whether the risks of surgery outweigh the expected benefit.
Diabetic Foot Osteomyelitis
Diabetes creates a near-perfect setup for bone infection in the feet. Nerve damage (neuropathy) means patients often cannot feel injuries, so a small wound can go unnoticed for days or weeks. Poor blood flow slows healing and weakens the immune response locally. And elevated blood sugar impairs white blood cell function. The result is that a seemingly minor foot ulcer can quietly erode through soft tissue and into the underlying bone.10PubMed. Current concepts in imaging diabetic pedal osteomyelitis
Diabetic foot osteomyelitis is one of the most common forms of the disease in adults, and it carries a real risk of amputation if not caught early. A clinical clue that raises suspicion is the “probe to bone” test: if a sterile metal probe inserted into a foot ulcer touches bone, the probability of underlying osteomyelitis is high. Diagnosis can be tricky because the bone changes of infection overlap with the bone changes caused by diabetic Charcot foot, a non-infectious condition that also deforms and destroys bone in the foot. Distinguishing the two often requires advanced imaging.
Diagnosing Osteomyelitis
Standard X-rays are usually the first imaging study ordered when osteomyelitis is suspected, but they have a significant limitation: bone destruction typically has to be at least 30 to 50 percent advanced before it becomes visible on a plain film. In early disease, X-rays can look completely normal. MRI is far more sensitive. A meta-analysis comparing the two in diabetic foot osteomyelitis found that MRI dramatically outperformed plain X-rays at detecting bone infection.11JAMA Internal Medicine. Magnetic Resonance Imaging for Diagnosing Foot Osteomyelitis: A Meta-analysis More recent multi-reader studies confirm that MRI has substantially higher sensitivity and is better at ruling out the disease when it is not present.12PubMed. Diagnostic performance comparison of conventional radiography to magnetic resonance imaging for suspected osteomyelitis of the extremities: a multi-reader study
Imaging alone, however, cannot tell you which bacterium is responsible. That is why bone biopsy remains the gold standard for guiding treatment. Cultures taken from the surface of a wound or a draining sinus tract are often misleading, because the bacteria growing on the skin surface are frequently different from the ones actually infecting the bone underneath.13PubMed Central. Osteomyelitis: approach to diagnosis and treatment A proper bone biopsy, obtained either during surgery or through a needle guided by imaging, gives the lab a sample of infected bone to culture, which allows the team to identify the exact organism and test which antibiotics it is susceptible to.14PubMed Central. Impact of diagnostic bone biopsies on the management of non-vertebral osteomyelitis A retrospective cohort study
Treatment and Why It Takes So Long
The traditional treatment of osteomyelitis after surgical cleaning of the infected bone involves four to six weeks of intravenous antibiotics.15PubMed. Duration of post-surgical antibiotics in chronic osteomyelitis: empiric or evidence-based? That duration reflects the slow pace at which bone heals and the difficulty of maintaining adequate antibiotic levels in bone tissue, which has a less generous blood supply than most organs. In practice, many patients start with intravenous therapy in the hospital and transition to oral antibiotics once the infection shows signs of responding, though the total treatment course remains long.
For chronic osteomyelitis, antibiotics alone are rarely enough. Surgery is almost always required to debride, meaning to physically remove, dead bone, scar tissue, and any infected hardware. The surgeon may also need to reshape the remaining bone cavity to eliminate dead space where bacteria could recolonize. One well-established approach to managing dead space is to fill the surgical cavity with antibiotic-loaded beads or cement. These are typically made from polymethylmethacrylate (PMMA) packed with antibiotics like gentamicin, and they release high local concentrations of drug directly at the infection site while keeping systemic drug levels low enough to avoid toxicity.16PubMed. The use of antibiotic-containing bead chains in the treatment of chronic bone infections In a large case series, this technique achieved infection control in about 90% of patients.17PubMed Central. Local antibiotic therapy in osteomyelitis
One drawback of PMMA beads is that they are not biodegradable and typically need a second surgery for removal. Newer approaches use bioactive glass or biodegradable carriers that dissolve over time while releasing antibiotics and promoting bone regeneration, potentially eliminating the need for a return trip to the operating room.18PubMed. Bioactive glass S53P4 to fill-up large cavitary bone defect after acute and chronic osteomyelitis treated with antibiotic-loaded cement beads: A prospective case series with a minimum 2-year follow-up
Hyperbaric Oxygen as an Add-On
For cases that keep relapsing despite standard surgery and antibiotics, hyperbaric oxygen therapy (HBOT) is sometimes added to the mix. The idea is straightforward: placing the patient in a pressurized chamber breathing pure oxygen drives much higher oxygen levels into tissues, including poorly perfused bone. Oxygen-starved bone heals poorly and resists infection poorly, so boosting local oxygen tensions helps white blood cells kill bacteria and supports new bone growth.
A systematic review of the available evidence found that adjunctive hyperbaric oxygen was effective in 80% of cohort studies, and roughly three-quarters of patients with complete follow-up data achieved infection clearance without relapse.19PubMed. Effectiveness of Hyperbaric Oxygen Therapy for the Management of Chronic Osteomyelitis: A Systematic Review of the Literature A more recent observational study of 80 patients with chronic foot osteomyelitis reported that 85% achieved total infection clearance maintained over an average of three years of follow-up, with no complications from the therapy itself.20PubMed. Outcome of Chronic Foot Osteomyelitis Treated With Hyperbaric Oxygen: An Observational Study These are encouraging numbers, though it is worth noting that hyperbaric oxygen has never been tested against a placebo in a large randomized trial for osteomyelitis, so the evidence remains somewhat limited in quality. Still, for patients who have failed multiple rounds of surgery and antibiotics, it represents a genuine option.
The Genetic Side of Susceptibility
Most people exposed to bacteria in a wound or through the bloodstream never develop osteomyelitis. The question of why some people’s immune systems fail to contain the infection before it reaches bone has led researchers to look at genetic variation. A systematic review of published studies found that variations in at least 17 genes appear to influence osteomyelitis susceptibility. Many of these genes encode parts of the innate immune system, particularly the receptors that detect bacterial invaders and the signaling molecules that coordinate the early inflammatory response.21PubMed Central. Genetic Determinants for Bacterial Osteomyelitis: A Focused Systematic Review of Published Literature
Separate work in a Greek population identified significant links between chronic osteomyelitis and variations in genes coding for several inflammatory signaling molecules, suggesting that people whose immune systems mount either too little or too much of an inflammatory response may be predisposed to developing chronic bone infection.22PubMed Central. Influence of interleukin 1alpha (IL-1alpha), IL-4, and IL-6 polymorphisms on genetic susceptibility to chronic osteomyelitis This research is still in its early stages and has not yet changed clinical practice, but it hints that osteomyelitis risk is not determined solely by exposure to bacteria. Your genetic makeup shapes how effectively your immune system detects and responds to invading organisms, and some people are wired in ways that leave them more vulnerable.
When Chronic Osteomyelitis Turns Cancerous
One of the rarest but most serious consequences of longstanding chronic osteomyelitis is the development of a type of skin cancer called Marjolin’s ulcer. This is a squamous cell carcinoma that arises in tissue subjected to decades of chronic inflammation, typically in the skin around a draining sinus tract that has been present for years.23PubMed. Marjolin’s ulcer associated with chronic osteomyelitis The cancer tends to be aggressive and has a higher rate of spread compared to squamous cell carcinomas that develop from sun damage. It is a compelling argument for pursuing definitive treatment of chronic osteomyelitis rather than simply living with recurring drainage, even when the day-to-day symptoms seem manageable.
Phage Therapy and What Comes Next
With antibiotic resistance climbing and some bone infections resisting every available drug, researchers have turned to bacteriophages, viruses that specifically target and kill bacteria. Phage therapy is not new (it dates to the early twentieth century), but its application to osteomyelitis is recent and still largely experimental. Case reports have documented successful clearance of chronic osteomyelitis caused by multidrug-resistant Pseudomonas aeruginosa after phage therapy was added to antibiotics and surgery, in cases where antibiotics alone had repeatedly failed.24PubMed Central. Bacteriophages as Adjuvant to Antibiotics for the Treatment of Periprosthetic Joint Infection Caused by Multidrug-Resistant Pseudomonas aeruginosa In one recent case, phage therapy helped clear a deeply resistant Pseudomonas infection involving retained surgical hardware, a scenario that would normally require complete hardware removal.25PubMed Central. Clearance of hypermutator XDR Pseudomonas osteomyelitis and hardware infection with adjunctive bacteriophage therapy
Phage therapy for osteomyelitis remains available only on a compassionate-use basis in most countries, and no large clinical trials have been completed. But the early results are promising enough that several research groups are working to develop standardized phage cocktails targeting the bacteria most commonly responsible for bone infections. For patients with truly pan-resistant organisms, where no antibiotic works, phages represent one of the few remaining avenues beyond amputation.